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Objectives/Hypothesis: The premise of this study
is that the membrane hypothesis of aging, also known
as the mitochondrial clock theory of aging, is the ba-
sis for presbyacusis. Furthermore, it is proposed that
treatment with antioxidants or dietary restriction
can attenuate age-related hearing loss. Many studies
have demonstrated a reduction in blood flow to spe-
cific tissues, including the cochlea, with aging. Hypo-
perfusion leads to the formation of reactive oxygen
metabolites (ROM). ROM are highly toxic molecules
that directly affect tissues including inner ear struc-
tures. In addition, ROM can damage mitochondrial
DNA (mtDNA), resulting in the production of specific
mtDNA deletions (mtDNA del
4977 [human] or mtDNA
del
4834 [rat]; also known as the common aging dele-
tion]. Previous corroborating data suggest that the
common aging deletion mtDNA
4834 may be associated
not only with aging but also with presbyacusis, thus
further strengthening the basis of the current studies.
In this study, experiments provide compelling evi-
dence that long-term treatment with compounds that
block or scavenge reactive oxygen metabolites atten-
uate age-related hearing loss and reduce the impact
of associated deleterious changes at the molecular
level. Study Design: Prospective randomized study.
Methods: One hundred thirty rats were randomly as-
signed to one of six groups with appropriate controls.
Animals were divided into the following treatment
arms: group 1, 30% caloric restriction; group 2, vita-
min E oversupplementation; group 3, vitamin C over-
supplementation; group 4, melatonin treatment;
group 5, lazaroid treatment; and group 6, placebo. In
addition, 10 animals were used to determine the ap-
propriate caloric restriction. All subjects underwent
baseline and every-3-month testing until their health
failed (range, 18–28 mo; average, 25 mo). This testing
included auditory sensitivity studies using auditory
brainstem response (ABR) testing, as well as tissue
analysis for mtDNA deletions using molecular biolog-
ical techniques. At the conclusion of the study, ani-
mals underwent a final ABR test and were tested for
mtDNA deletions in brain and inner ear tissues, and
the opposite ear was used for histological analysis.
Results: Results indicated that the 30%-caloric-
restricted group maintained the most acute auditory
sensitivities, the lowest quantity of mtDNA deletions,
and the least amount of outer hair cell loss. The
antioxidant-treated subjects had improved auditory
sensitivities, and a trend for fewer mtDNA deletions
was observed compared with the placebo subjects.
The placebo subjects had the poorest auditory sensi-
tivity, the most mtDNA deletions, and the greatest
degree of outer hair cell loss. Conclusions: Interven-
tion designed to reduce reactive oxygen metabolite
damage appears to protect against age-related hear-
ing loss specifically and aging in general. This is re-
flected by an overall reduction in mtDNA deletions.
These data also suggest that the common aging dele-
tion appears to be associated with presbyacusis, as
demonstrated by an increased frequency of the
mtDNA del
4834 in the cochleae with the most signifi-
cant hearing loss. Nutritional and pharmacological
strategies may very well provide rational treatment
options that would limit the age-associated increase
in ROM generation, reduce mtDNA damage, and re-
duce the degree of hearing loss as the organism ad-
vances in age. Key Words: Antioxidants, reactive oxy-
gen metabolites, anti-aging, presbyacusis.
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INTRODUCTION
The premise of this study is that the membrane hy-
pothesis of aging, also known as the mitochondrial clock
theory of aging, is the basis for presbyacusis. This study
expands on the fact that aged animals have a reduction in
blood supply to the cochlea. It is hypothesized that this
generalized hypoperfusion leads to the generation of reac-
tive oxygen metabolites (ROM). The ROM damage mito-
chondria, manifesting as a reduction in mitochondrial
membrane potentials and an increase in mitochondrial
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727DNA (mtDNA) deletions with concomitant hearing loss.
This study also demonstrate that long-term treatment
with compounds that either block or scavenge reactive
oxygen metabolites have a protective effect on age-related
hearing loss and the associated alterations at the genomic
level.
This study investigates new hypotheses designed to
enhance the understanding of the molecular and biological
mechanisms of presbyacusis. The primary purpose of
these experiments was to determine whether the mem-
brane hypothesis of aging has a fundamental role in age-
associated hearing loss. Furthermore, these experiments
were designed to determine whether diet restriction and
treatment with compounds known to reduce damage from
ROM will affect the aging process in general, and presby-
acusis in particular.
The process of aging is associated with many molec-
ular, biochemical, and physiological changes including in-
creases in DNA damage, reduction in mitochondrial func-
tion, decreases in cellular water concentration, ionic
changes, vascular insufficiencies, and decreased elasticity
of cellular membranes. One contributing factor to this
process is altered vascular characteristics, such as re-
duced erythrocyte velocity and vascular plasticity, as well
as increased vascular permeability.
1,2 These age-related
changes result in reductions in oxygen and nutrient deliv-
ery, as well as waste elimination.
3,4 Such functional alter-
ations favor the production of ROM. In addition, there is
support in the literature for an age-associated reduction in
endogenous enzymes that protect from ROM damage, in-
cluding superoxide dismutase, catalase, and glutathione
peroxidase.
5 Collectively, these changes enhance the gen-
eration of ROM. ROM are responsible for producing mito-
chondrial DNA damage by causing mutations in the mi-
tochondrial genome. Specific mutations are known to be
directly proportional to aging, such as the common aging
deletion in humans, which is 4,977 base pairs (bp) in
length, and in rats (4,834 bp). When mtDNA deletions
reach a certain level, the mitochondria become bioener-
getically inefficient. Investigators have shown that aged
rats, monkeys, and humans have reductions in mitochon-
drial function and increases in mtDNA deletions in heart,
brain, liver, and skeletal muscle.
6–8 To develop the basis
for this study, the following topics are discussed: presby-
acusis, reactive oxygen metabolites, mitochondrial func-
tion and mitochondrial DNA deletions, aging, and antioxi-
dants.
HISTORICAL PERSPECTIVES AND REVIEW OF
THE LITERATURE
Presbyacusis
“Biological aging appears to be a physiological
process engendered by the genotype and the adap-
tive norm of the species. Superimposed on the inher-
ited processes seems to be the gradual accumulation
of errors in DNA, which is probably related to a
decline in normal mechanisms of repair.”
Dr. Schuknecht displayed tremendous insight when
he wrote these lines some two decades ago. That the
concepts he had outlined remain relevant today is an
affirmation of his stature as a scientist and clinician.
Aging research has fortified these precepts as an accurate
and meaningful perspective on senescence and its many
manifestations, such as presbyacusis.
Presbyacusis is characterized by the progressive de-
terioration of hearing associated with aging and is the
most common cause of adult auditory deficiency in the
United States, affecting approximately 23% of the popu-
lation between 65 and 75 years of age and 40% of the
population older than 75 years of age.
9 Thus the socioeco-
nomic ramifications are staggering. While presbyacusis is
common in industrialized societies, age-related hearing
loss is less pronounced in other societies. This discrepancy
has been attributed to many factors, including genetics,
diet, and socioeconomic and environmental factors.
10,11
Reactive Oxygen Metabolites or Free Oxygen
Radicals
Reactive oxygen metabolites are species that contain
an unpaired number of electrons making them chemically
reactive and extremely toxic to cellular and subcellular
structures. It has been speculated that ROM are involved
in more than 100 clinical conditions.
12 They are produced
in vivo during mitochondrial respiration, as well as via
auto-oxidation of chemical and biological molecules. ROM
are also environmental contaminants, can be formed from
ionizing and ultraviolet radiation, and occur in response to
hypoperfusion or ischemia followed by reperfusion.
There is extensive support in the literature for the
protective effects of antioxidants and reactive oxygen me-
tabolite scavengers. For example, tocopherols (vitamin E)
decrease atherosclerosis and delay death from myocardial
infarction, presumably by inhibiting lipid peroxidation.
13
Carotenoids, such as b-carotene and other plant pigments,
may also have preventive effects against cancer and car-
diovascular disease.
14,15 Available data also suggest that
many of the pathological correlates of Alzheimer’s disease
are precipitated by free radical–induced and oxidative
stress–induced mechanisms.
16 Similarly, Parkinson’s dis-
ease has also been associated with oxidative stress, in-
creased lipid peroxidation, reduced levels of glutathione,
high concentrations of iron, and free radical generation
via autocatalytic mechanisms within neuromelanin-
containing catecholaminergic neurons.
17
Experimentally and clinically, it is well known that a
primary source of ROM generation is through oxidative
phosphorylation, ischemia/reperfusion, or prolonged hypo-
perfusion, such as is seen in myocardial infarction, cere-
brovascular accidents, aging, and, possibly, sudden senso-
rineural hearing loss and presbyacusis. It is clear that in
the aging cochlea there is a significant reduction of blood
supply
2 and the ongoing need for energy generation
through oxidative phosphorylation. Thus these two pro-
cesses allow for the generation of ROM within the cochlea.
Vascular Changes Associated With Aging
The aging process is clearly linked with alterations in
circulatory function. Studies have demonstrated markedly
decreased flow within the circulatory system in the elderly
population.
3,4 Prolonged periods of reduced blood flow
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within tissues culminating in the generation of damaging
ROM.
Various lines of research have centered on the con-
cept that altered blood flow and/or oxygen delivery results
in inner ear hair cell damage and hearing loss. In a human
cadaveric study of cochlear vessels, an age-related, grad-
ual loss of capillaries in the spiral ligament of the scala
vestibuli was observed, with an increase in intravascular
strands and avascular channels. Similar but less pro-
nounced findings were noted in the spiral ligament in the
scala tympani.
18 Another human cadaver study, using a
microsphere technique to quantify blood flow, found di-
minished flow in morphometrically normal–appearing
basal turn capillaries.
19 Changes in whole blood viscosity
and red blood cell rigidity have been correlated with high-
frequency hearing loss in elderly humans.
20 Furthermore,
a series of in vivo experiments using intravital microscopy
of the cochlear microvasculature demonstrated age-
dependent, statistically significant reductions in mean
erythrocyte velocity and significant increases in capillary
permeability.
2 In contrast, Axelsson
21 noted no significant
differences in cochlear blood vessels of young and old
guinea pigs. However, there were more failures in con-
trast filling of the older animals’ vessels, because of more
frequent ruptures of the vessels.
21 It is possible that this
may in part be due to increased vascular fragility that is a
common feature of aged vasculature, a speculation en-
dorsed by Dr. Axelsson. Furthermore, these findings may
also be secondary to increased vascular permeability,
which is a common sequela of ischemic injury.
Effects of Hypoxia on the Inner Ear
The effects of cochlear hypoxia on auditory function
have been extensively studied. There is a direct correla-
tion between hypoxia and decreased hearing sensitivity.
Studies inducing hypoxia by inspiration of 100% nitro-
gen,
22 tracheal clamping and cessation of respiration,
23
and vessel occlusion
24 have all shown significant alter-
ations of auditory sensitivity as measured by compound
action potentials, summating potentials, cochlear micro-
phonics, and otoacoustic emissions.
25,26
Decreased blood flow from a variety of causes includ-
ing hypertension, atherosclerosis, noise exposure, or aging
promotes hypoxia with formation of ROM and resultant
tissue/organ damage.
27,28
Mitochondrial DNA Deletions
Mitochondria are unique organelles possessing their
own DNA as well as their own enzymatic constituents to
allow for transcription and translation of genetic informa-
tion into proteins. Each mtDNA codes for a complete set of
ribosomal (rRNA) and transfer RNA (tRNA). In addition,
mtDNA codes for 13 of the approximately 60 polypeptides
necessary for oxidative phosphorylation. These include 7
of the 25 subunits of respiratory complex I (ND1–ND4, 4L,
5, and 6) (reduced nicotinamide adenine dinucleotide
[NADH]-ubiquinol-oxidoreductase), 1 of the approxi-
mately 9 subunits (cyt b) of respiratory complex III
(ubiquinol-cytochrome c oxidoreductase), 3 of the 13 sub-
units of respiratory complex IV (COI, COII, and COIII)
(cytochrome c oxidase), and 2 of the 12 subunits of respi-
ratory complex V (ATP6 and ATP8) (ATP synthase). The
remaining subunits of these complexes are encoded by
nuclear DNA.
29
It has been proposed that mitochondrial genomic mu-
tations may be a major cause of human diseases. The first
patient reported with a mtDNA deletion as a cause of illness
was reported in 1959.
30 Luft is often credited with demon-
strating the importance of mitochondrial medicine.
31 Mito-
chondrial mutations followed by cytoplasmic segregation has
been shown to contribute to neuromuscular disorders such
as Kearns-Sayre/chronic external ophthalmoplegia plus syn-
drome,
32 mitochondrial encephalomyopathy, lactic acidosis,
and stroke-like episodes (MELAS),
33 subacute necrotizing
encephalomyopathies, SNE (Leigh syndrome) and progres-
sive neuronal degeneration of childhood (Alpers syn-
drome),
34 and myoclonic epilepsy associated with ragged-red
muscle fibers (MERRF).
29 Interestingly, as many as 67% of
patients with mtDNA disorders are known to manifest sen-
sorineural hearing loss.
35
Experiments performed since 1989 have demon-
strated that mtDNA deletion with gene induction is also
associated with hypoxia. Corral-Debrinski et al.
36 have
found a specific mtDNA deletion occurring at increased
frequency in ischemic hearts. They concluded that isch-
emic hearts have increased mtDNA damage and oxidative
phosphorylation gene expression that may be associated
with oxidative phosphorylation deficiency. In addition,
there is evidence suggesting 5- to 12-fold elevations in
mtDNA deletions in the brain associated with chronic
hypoxia.
37
Deletions of mtDNA with subsequent segregation
and enrichment of the deletions throughout life are con-
tributing factors in the aging process.
6 It has been shown
that mtDNA deletions in the human heart are age depen-
dent.
6 Mitochondrial mutations occur and accumulate
continuously until death. Cells that accumulate large
numbers of mitochondrial mutations become bioenergeti-
cally deficient, which explains their important role in
many human diseases.
38
Mitochondrial and nuclear DNA are exposed to a
significant amount of oxidative damage. Studies have
shown that increasing amounts of ROM occur as a func-
tion of age, which leads to an increase in membrane per-
oxide content and rapidly exceeds the capacity of homeo-
static protection.
39 Thus there is extensive support that
mtDNA deletions accumulate with age and disease.
40,41
Deafness has also been shown to have an association
with mtDNA deletions. It has been suggested that mito-
chondrial diseases should be considered in cases of pro-
gressive sensorineural hearing loss, especially with the
coexistence of multisystem involvement.
42 A 10.4-kb
mtDNA deletion has been identified in association with
maternally transmitted diabetes and deafness, without
ophthalmoplegia or mitochondrial myopathies, which was
the hallmark of mtDNA deletion syndromes.
43 Other stud-
ies have identified mutations in the tRNA(Leu)(UUR)
gene in a large pedigree with maternally inherited dia-
betes mellitus type II and deafness.
44 A 3,243-point mu-
tation (A3G) has been demonstrated in a patient
with sensorineural deafness without diabetes.
45 Several
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chondrial DNA mutations and presbyacusis, including a
study demonstrating that older patients with presbyacu-
sis had a higher frequency of the common aging deletion
(4,977 bp) compared with similar-aged patients without
presbyacusis.
46 A significant difference in mtDNA dele-
tion was noted in human archival temporal bones. Specif-
ically, 14 of 17 aged patients with presbyacusis had the
4,977-bp deletion compared with 8 of 17 control patients
with normal hearing.
47
Aging
Aging is the progressive accumulation of metabolic
and physiological changes associated with an increasing
susceptibility to disease. There are many hypotheses in
the current literature providing explanations for senes-
cence. Three of the most convincing theories are the te-
lomerase theory of aging, the “dysdifferentiation” hypoth-
esis of aging, and the membrane hypothesis of aging (also
referred to as the mitochondrial clock theory of aging).
The telomerase theory of aging suggests that there is
a reduction in telomere length over time. The end of a
chromosome is made up of a structure called the telosome.
The tip of the telosome is a region of DNA repeat se-
quences and associated proteins called the telomere. It is
hypothesized that DNA transcription and replication are
affected by position effects mediated by the telomere. Re-
duction in the length of the telomere and alterations in its
chromatin assembly may explain the instability that oc-
curs during senescence, as well as the immortalization
process in vitro.
48 Although many aspects of telomerase
activity remain undefined, it has been hypothesized that
the balance between telomere shortening and telomerase
activity underlies cellular aging processes.
The dysdifferentiation theory suggests that aging is a
continuum of programmed differentiation leading to ei-
ther a cessation of normal gene activity or a systematic
activation of genes whose effects are deleterious to cellular
function. Support for this theory is provided by apoptosis
(programmed cell death) studies in hermaphroditic
worms. These experiments elegantly elaborated the ge-
netic mechanisms responsible for controlling cell death.
The maintenance of homeostasis for cellular metabolism
and function consumes a large fraction of total body en-
ergy expenditure. This is engineered by the delicate bal-
ance between cellular proliferation and death. For exam-
ple, the Bcl-2 gene appears to prevent oxidative damage to
cellular organelles and lipid membranes.
49,50 Another pro-
tein that appears to operate as an accessory to Bcl-2 is a
21-kD protein referred to as Bax. The ratio between Bcl-2
and Bax appears to determine survival or death following
an apoptotic stimulus. Specifically, elevated expression of
Bcl-2 appears to be preventive, while that of Bax favors
the apoptotic process.
49
The membrane hypothesis of aging states that aging
is related to decreasing effectiveness of cellular protective
and reparative mechanisms. This yields biochemical and
metabolic errors, which progressively accumulate, result-
ing in cell death.
51 The hypothesis further postulates that
cellular senescence is attributable to the cross-linking ac-
tion of ROM within the cellular membrane. In addition,
ROM lead to lipid peroxidation, polysaccharide depoly-
merization, nucleic acid disruption, and oxidation of sulf-
hydryl groups leading to enzyme inactivation.
52 Therefore
the membrane hypothesis of aging suggests that ROM-
induced cell membrane structural damage is the primary
mediator in cellular aging.
53
Careful analysis of the above mechanisms suggests
that certain aspects of the three leading theories of aging
may be interrelated. That is, free radical species lead to
genetic and cellular alterations resulting in cellular dys-
function and, consequently, senescence. It is even more
intriguing to realize that a trigger for the Bax gene is
ROM.
54 Thus a critical analysis of the prominent hypoth-
eses of aging suggests that aspects of all three theories are
likely to apply. Specifically, the generation of ROM dam-
ages cellular integrity, which may lead to alterations in
gene expression, including telomere shortening and acti-
vation of Bax genes resulting in aging, apoptosis, and,
ultimately, death.
Primary Treatment Interventions
The primary treatment interventions used in these
experiments were the following:
Diet restriction. It is well known that a 30% caloric
dietary restriction can enhance longevity by 30% to 50%.
The putative mechanism is a reduction in metabolism and
oxidation reactions and hence, a significant reduction in
the generation of ROM.
Vitamin E. Vitamin E (tocopherol) is a potent fat-
soluble antioxidant. The most active naturally occurring
compound is RRR-a-tocopherol. Polyunsaturated fatty ac-
ids (PUFAs) are liable to auto-oxidation. Each fatty acid
free radical that is oxidized damages about three other
PUFA molecules, thus producing a chain reaction that
expands geometrically. Vitamin E can readily donate hy-
drogen atoms to terminate this chain reaction. The vita-
min also appears to be essential for the protection of
circulating lipoproteins and the correct functioning and
stability of cell membranes.
Vitamin C. Vitamin C or ascorbic acid is a water-
soluble vitamin. It cannot be endogenously synthesized in
certain species, including humans; therefore its require-
ment must entirely be met by dietary intake. It is an
effective scavenger for superoxide (O2
.-), thiol (sulfur-
centered), singlet O2, and hydroxyl radicals. It has been
shown to recycle a-tocopherol in lipid membranes, thus
delaying the onset of peroxidation in isolated human low-
density lipoproteins (LDLs).
Melatonin. Melatonin (N-acetyl-5-methoxytryptamine)
is an indole hormone primarily secreted by the pineal gland.
Although primarily known for its effect on entrainment
pathways of the biological clock and actions on photoperiodic
time, melatonin is also an important neural antioxidant and
free radical scavenger. It is believed to work via electron
donation to directly detoxify free radicals such as the hy-
droxyl radical. In addition, melatonin has been found to
protect cells (in vivo as well as in vitro) against oxidative
damage induced by a variety of free radical–generating
agents and processes. It is also effective in protecting nuclear
DNA, membrane lipids, and, possibly, cytosolic proteins
from oxidative damage. In addition, evidence suggests that it
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zymes such as superoxide dismutase, glutathione peroxi-
dase, and nitric oxide synthase.
Lazaroids. Lazaroids are 21-aminosteroids with no
glucocorticoid, mineralocorticoid, or other hormonal prop-
erties. They are multimechanistic inhibitors of lipid per-
oxidation. Lazaroids scavenge free radicals and stabilize
cell membranes by decreasing fluidity, preserving vitamin
E content in these membranes, and increasing surface
viscosity. They have demonstrated efficacy in improving
neurological outcome after central nervous system
trauma, subarachnoid hemorrhage, and ischemia.
MATERIALS AND METHODS
Fischer 344 rats were obtained from Harlan Inc. (Indianap-
olis, IN). A total of 130 2-month-old rats were used for these
experiments. All procedures and protocols were reviewed and
approved by the institution’s Care for Experimental Animals
Committee. All animal experiments were performed in a humane
manner according to standards established by the National In-
stitutes of Health (Bethesda, MD).
Subjects were maintained in individual cages at 21°C to
22°C with a 12:12-hour light-dark cycle initiated at 7:00 A.M. Food
and water were available ad libitum to all groups with the excep-
tion of diet-restricted subjects.
To determine the appropriate dietary restriction, a group of
10 animals was originally studied for a period of 1 month. These
10 animals were placed in metabolic cages where strict caloric
intakes and urinary and stool outputs were recorded. The ani-
mals ingested 16 g 6 3 g of a standard rodent diet formulation per
day. Thus the appropriate caloric restriction was calculated to be
11.2 g (30% restriction) of feed per day for the caloric-restricted
group.
The remaining 120 rats were randomly assigned to one of
the following six groups: group 1: 30% caloric restriction (n 5 20);
group 2: vitamin E oversupplementation (2.475 mg/d) (n 5 20);
group 3: vitamin C oversupplementation (4.44 mg/d) (n 5 20); group
4: melatonin treatment (0.1 mg/d) (n 5 20); group 5: lazaroid treat-
ment (1.25 mg/d) (n 5 20); and group 6: placebo (matrix pill)
(n 5 20).
The subjects were initially anesthetized using ketamine and
xylazine (100 mg/kg and 15 mg/kg, respectively, intramuscularly)
and supplemented with ketamine as required.
To simplify identification of each individual rat and to elim-
inate the possibility of inadvertently misidentifying the subject,
an electronic identification (ID) microchip (Avid, Norco, CA) was
inserted into each animal and read with a scanner before any
testing or treatment. In brief, the posterior nuchal region was
prepared and draped in a sterile manner. A 3-mm incision was
made posteriorly, and the ID microchip inserted. The wound was
closed with an interrupted 4-0 Vicryl suture.
After the microchip insertion, a separate incision was made
immediately cephalad to the microchip incision and the appropri-
ate pellet (per previous randomization) was inserted into the
subcutaneous tissues. This wound was closed with one 4-0 Vicryl
suture. The pellets were purchased from Innovative Research
(Sarasota, FL). The pellets have been tested extensively to verify
stated timed-release parameters, appropriate dosing, and appro-
priate blood levels. The pellets selected for these experiments
were 3-month pellets and were guaranteed to provide basal levels
of the particular drug or vitamin throughout the entire time
course.
Drug Dosages
Dosages of drugs used were as follows: vitamin E, one pellet
implanted with 222.75 mg vitamin E, each delivering 2.475 mg/d;
vitamin C, two pellets implanted with 200 mg vitamin C, each
delivering 4.44 mg/d; melatonin, one pellet implanted with 9 mg
melatonin, each delivering 0.1 mg/d; and lazaroid, one pellet
implanted with 112.5 mg drug, each delivering 1.25 mg/d.
In addition, random assays were performed on animals to
determine blood levels of vitamin E and melatonin groups at
three separate time points during the life of the pellet. The
technique to perform the assays used high-pressure liquid chro-
matography.
Auditory Brainstem Response Measurements
Auditory brainstem response (ABR) measurements were
collected every 3 months from 2 months of age until the death of
the animal. Each ear was studied for auditory sensitivity. Sub-
jects were anesthetized using ketamine and Rompun (100 mg/kg
and 15 mg/kg, respectively, intramuscularly) and supplemented
with ketamine as required. The subject’s temperature was main-
tained at 38°C 6 1°C with a heating blanket and monitored with
a rectal probe.
Signal generation. The test stimulus consisted of tone-
bursts with a rise/fall time of 1 millisecond, a duration of 15
milliseconds, and a period of 100 milliseconds. Intensity series
were obtained at 3, 6, 9, 12, and 18 kHz, ranging from 0 dB sound
pressure level (SPL) to 100 dB SPL. These stimuli were generated
using a digital-to-analogue converter (model DA3–2, Tucker
Davis Technologies, Gainesville, FL). The output of the digital-
to-analogue converter was connected to a programmable attenu-
ator (model PA4,Tucker Davis Technologies), a weighted summer
(model SM3, Tucker Davis Technologies), a headphone buffer
(model HB6, Tucker Davis Technologies), and an earphone (mod-
el DT-48, Beyer Dynamic, Heilbronn, Germany) that was placed
in close approximation to the tympanic membrane of the animal.
A sampling frequency of 100 kHz was used to generate the signal.
The signals were calibrated at the tympanic membrane using a
probe microphone (model ER-7C, Etymotic Research, Elk Grove
Village, IL). The output of the microphone was connected to an
analogue-to-digital converter (model AD2, Tucker Davis Technol-
ogies) and a Pentium computer. An automatic calibration routine
was used for on-line calibration.
Recording. Sterile platinum needle electrodes (model E2,
Grass Instruments, Quincy, MA) were placed under each pinna
and at the vertex of the subjects (under anesthesia). The elec-
trodes were connected to a biological amplifier (model P5 series,
Grass Instruments) with the gain setting at 3 100,000. The
response was filtered between 0.3 and 3 kHz. The output of the
amplifier was connected to an analogue-to-digital converter (mod-
el AD2, Tucker Davis) and a Pentium computer. The responses
were digitized with a sampling frequency of 50 kHz. For each
recording, a 20-millisecond neural response was averaged 1,024
times. Thresholds were identified when an N1 response 1 mV
above baseline was observed, using a standard protocol.
Isolation of Intact Mitochondria From Muscle
Samples
Isolation of mitochondria from muscle was performed as
previously described.
55 In brief, the muscle specimen, weighing
approximately 1 g, was freed of any fat or connective tissue and
rinsed in cold, nonionic isolation buffer containing 210 mmol/L
mannitol, 70 mmol/L sucrose, 1 mmol/L ethyleneglycol-bis-(beta-
aminoethylether)-N,N,N9,N9-tetra-acetic acid (EGTA), 0.5% BSA,
and 5 mmol/L N-2-hydroxyethylpiperazine-N-2-ethanesulfonic
acid (HEPES), pH 7.2. The specimen was processed in approxi-
mately 0.5-g batches with a Thomas (Thomas Scientific, Swedes-
boro, NJ) tissue slicer. The thinly sliced muscle was collected into
a 50-mL tube, suspended in 10 mL isolation buffer/g muscle
tissue. The muscle tissue was homogenized using 10 passes in a
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sulting sample was centrifuged at 1500 3 g for 5 minutes at 4°C.
The supernatant was decanted into a fresh tube, the pellet was
discarded, and the sample underwent repeat centrifugation. The
supernatant was decanted and centrifuged at 8000 3 g for 15
minutes. The mitochondrial pellet was suspended in 30 mL iso-
lation buffer and centrifuged again at 8000 3 g for 15 minutes.
The washed mitochondrial pellet was resuspended in 0.1 mL of
the isolation buffer for each gram of muscle used. This sample
could then be stored at 270°C. For protein estimation, a 30-mL
aliquot was removed and centrifuged at 8000 3 g for 15 minutes,
and the pellet was resuspended in isolation buffer without BSA.
Tissue Sources
The tissues harvested from the animal subjects included
brain, auditory nerve, and stria vascularis. All tissues were used
immediately or stored at 270°C for later use.
DNA Extraction
Animal tissues were harvested and stored at 270°C, until
the time of DNA extraction. The samples were homogenized in 10
mmol/L Tris (pH 8) containing 1 mmol/L EDTA buffer and incu-
bated overnight at 56°C with 15 mL Proteinase-K (10 mg/mL) in
0.5 mL digestion buffer consisting of 10 mmol/L Tris (pH 8), 10
mmol/L EDTA, 50 mmol/L NaCl, and 2% sodium-dodecyl sulfate.
Standard extraction protocols for DNA were used with phenol,
chloroform, and isoamyl alcohol. The proteins were removed from
the sample solution with phenol and chloroform, (25:24) both of
which served as separate organic solvents and hence deprotein-
ized more efficiently. The tissue extracts were centrifuged at
10,000 3 g at room temperature to separate mtDNA from cellular
debris and protein. The supernatant was drawn off, and the
residual phenol removed with equal volumes of chloroform and
isoamyl alcohol (24:1). This subsequent extraction with chloro-
form removed the remaining traces of phenol from the prepara-
tion. A 1/10 volume of 3 mol/L NaOAc and 1/100 volume of 1 mol/L
MgCl2 were added, and mtDNA was recovered by precipitation
with 2 volumes of cold ethanol. This preparation was stored at
270°C for 60 minutes, and the precipitate was recovered by
centrifugation at 12,000 rpm for 30 minutes (4°C). The superna-
tant was removed, and the pellet washed with 70% ethanol,
air-dried, and redissolved in Tris-Edta buffer at the desired con-
centration. DNA concentrations were determined spectrophoto-
metrically using optical densities of 260 and 280 nm, and aliquots
were used for polymerase chain reaction (PCR).
There are technical differences in isolating DNA from skel-
etal muscle compared with other tissues. The methodology neces-
sitates special attention for the isolation of tightly coupled mito-
chondria. Our laboratory has used the modifications as
previously described.
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Polymerase Chain Reaction
Oligonucleotide primers were designed in our laboratory
and synthesized by Fisher Biotech (Pittsburgh, PA) to amplify
several distinct regions of the rat, mouse, and human mtDNA
genome. Of particular interest is the cytochrome b gene, the ND1
segment of the 16S rRNA region and a 4,834-bp deletion in rats.
PCR is used to amplify the base-pair products that correspond to
these regions. Appropriate positive and negative controls were
run and then sequenced to authenticate the PCR products. The
PCR reaction contained 100 to 200 mg of test sample, 200 mmol/L
of each deoxynucleotide triphosphate, 50 mmol/L KCl, 10 mmol/L
Tris-HCl (pH 8.3), 1.5 mmol/L MgCl2, 0.01% (wt/vol) gelatin, 1
mmol/L of each primer, and5Uo fT a qpolymerase in a final
volume of 100 mL. The thermal cycling parameters were as fol-
lows: initial denaturation at 94°C for 3 minutes, followed by 30
cycles of denaturation at 94°C (for 30 s), annealing at 56°C (for
30 s), and extension at 72°C (for 1 min).
Gel Electrophoresis
The amplified PCR products were separated by electro-
phoresis on 1.5% agarose gel containing ethidium bromide. The
gels were read under ultraviolet light and imaged. Agarose gel
concentrations vary depending on fragment length. Thus for
larger fragments a 1% agarose gel was used.
DNA Sequencing
Details of sequencing have been described previously.
57 The
age and, possibly, presbyacusis-dependent mtDNA region was
selectively amplified, and the resulting fragment was gel purified.
Asymmetric PCR was performed with primers at a 1:100 ratio. A
direct sequencing of the single-stranded mtDNA was made by
asymmetric PCR using the “fmol” DNA Sequencing System (Pro-
mega Co., Madison, WI).
Histology
Subjects were deeply anesthetized. Cardiac puncture was
performed, and the animal was perfused with 2.5% glutaralde-
hyde solution in a veronal acetate buffer freshly normalized to a
pH of 7.4. The bullae were rapidly removed, and the cochleae
were reperfused through the oval and round windows. The co-
chleae were stored at 4°C for 48 hours, then perfused with 1%
osmium tetroxide in veronal acetate buffer normalized to a pH of
7.4 for 30 minutes. After perfusion, the organs were dehydrated
using ethanol of ascending strength from 30% to 70%. The co-
chleae were decalcified overnight in 0.35 mol/L of EDTA in vero-
nal acetate buffer normalized to a pH of 7.4 at room temperature.
After decalcification, the organ of Corti was dissected in 70%
ethanol. Each turn was mounted with glycerol and examined
under an optical microscope. The hair cells were counted at orig-
inal magnification 3 630, using a Carl Zeiss GFL (Carl Zeiss Inc.,
Goettingen, Germany) differential interference contrast micro-
scope. The data were used to generate cytocochleograms as a
frequency position map based on the following mathematical
derivation:
F 5 A(10
ax 2 k),
where F stands for frequency, A 5 0.64, a 5 2.1, x is expressed as
a proportion of basilar length, and k 5 0.85.
Statistical Methodology
Outcome variables. The hearing levels for five frequencies
(3, 6, 9, 12, and 18 kHz) were tested separately.
Multiple comparisons. A Bonferroni adjusted P value of
.01 (P 5 .05/5) was used to determine statistical significance for
each overall test for a treatment group effect for the five frequen-
cies. If the overall test was not significant, tests between individ-
ual treatment groups were not performed. If the overall test was
significant, comparisons between treatment groups, two at a
time, were performed and a P value of .05 or less was considered
statistically significant.
Analysis methods. To compare the baseline, pretreatment
values, one-way ANOVA was performed. To make use of serial
observations, repeated-measures analysis was performed using
the SAS PROC MIXED
58 procedure. The model assumed a corre-
lation between observations that decreased with the time (i.e., a
lower correlation between the observations at months 15 and 25
compared with those between months 15 and 20 or between
months 20 and 25). The PROC MIXED procedure allows subjects
to be included even if observations are not available for all times.
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served at each month.
Four analyses were performed. These were restricted to all
data available at 25 months, all data from 20 months onward, all
data from 15 months onward, and all data from 12 months on-
ward. The data from the oldest animals were of greatest interest,
but earlier data were also included.
RESULTS
This randomized prospective study was completed
over a 3-year period. A total of 120 subjects were initially
tested, and all subjects were studied throughout their life
span. At the conclusion of the experiments, there were five
animals available for analysis in the diet-restricted group
(mean age, 27 mo), four in the vitamin E group (mean age,
26 mo), four in the vitamin C group (mean age, 24.5 mo),
three in the melatonin group (mean age, 25 mo), three in
the lazaroid group (mean age, 26 mo), and three in the
placebo group (mean age, 26).
Blood Levels of Vitamin E and Melatonin
To verify the appropriate functioning of the matrix
drug delivery system, serum for vitamin E and melatonin
testing was obtained. Other assays are available for the
remaining treatment options, but they are considered un-
reliable and extremely expensive. Testing was performed
at four separate time points: at baseline, 1 week after
implantation of the 90-day pellet, 6 weeks after implan-
tation, and just before the pellet was due to be changed
(85–89 d). Levels of the supplemented vitamin or hormone
were in the appropriate range.
The vitamin E group baseline levels were 9 6 0.5
nmol/mL. The levels at 1 week, 6 weeks, and just before
pellet change were 16.4 nmol/mL 6 1.7 nmol/mL. Melato-
nin levels are subject to diurnal variation. Testing was
performed at approximately 10:00 A.M. and revealed a
baseline level of 59.5 pg/mL 6 5 pg/mL. The levels at 1
week, 6 weeks, and just before pellet change were 1,446
pg/mL 6 145 pg/mL.
Auditory Sensitivity Results
Baseline auditory thresholds for all subjects at 2 to 4
months of age were in the range of previous studies in our
laboratory as well as other laboratories, and were between
15 and 35 dB in the frequencies tested. Over the span of 24
to 27 months the thresholds shifted the least in the diet-
restricted groups and the treated subjects. The threshold
shifted the most in the placebo group as tested at 26
months. The difference between the restricted-diet group
and the placebo group was statistically significant (P ,
.01). The antioxidant-treated groups had a statistically
significant protective effect when compared with the pla-
cebo group, but this effect was frequency specific (P , .05).
In other words, not all frequencies showed a statistically
significant response. Specifically, the vitamin E group ex-
perienced statistically better auditory thresholds at 6, 9,
and 12 kHz (P , .05), but not at 3 or 18 kHz. Vitamin
C–treated animals showed a statistically significant lower
threshold compared with the placebo group at all frequen-
cies except 3 kHz. Melatonin results were statistically
better than placebo results at all frequencies except 12
kHz. Lazaroid was better than placebo only at 12 kHz.
There was a progressive reduction of auditory sensi-
tivity which began at approximately 6 to 9 months of age
in all groups. The greatest amount of hearing loss oc-
curred over the last 12 months of life. The least amount of
presbyacusis was observed in the diet-restricted subjects.
The other treated animals experienced better hearing sen-
sitivities than the control group, and this was statistically
significant for all groups (P , .01) with the exception of
the lazaroid group, and the overall effect varied with fre-
quency. Figure 1 is a graph depicting cumulative audio-
logical data of all groups.
Table I summarizes the tests for overall treatment
effects for each of the four analyses. The first four frequen-
cies showed significant treatment effects in all of the anal-
yses. A treatment effect could not be confirmed for a fre-
quency of 18 kHz for the two analyses restricted to
animals observed for 20 months or more.
The means for the various groups and the results of
the comparisons between groups within the repeated-
measures analysis are available in the detailed thesis
(unpublished data).
Mitochondrial DNA Deletions
To study changes in mitochondrial DNA, we evalu-
ated brain, auditory nerve, and stria vascularis for cyto-
chrome b, the ND-1 16S rRNA region of the mitochondrial
genome and the common aging deletion (mtDNA
4834). Cy-
tochrome b and ND-1 16S rRNA are used as controls to
verify the presence of mitochondrial DNA while the
mtDNA
4834 is the test of interest that provides a molecu-
lar marker of aging. All specimens were positive for cyto-
chrome b and ND-1 16S rRNA, verifying the presence of
mtDNA. A small piece of muscle was harvested at every
3-month testing interval, thus allowing the opportunity to
determine when the deletion was first apparent. The com-
mon aging deletion gradually appeared at 9 months of age
in all groups except the restricted-diet group. This group
did not show evidence of the common aging deletion until
16 months of age. Quantification studies revealed an age-
appropriate increase in the mtDNA
4834, and DNA se-
quencing verified the authenticity of the PCR products.
The most rapid accumulation of the mtDNA
4834 was evi-
dent in the ad libidum diet (placebo); the other treated
groups had a slower accumulation of the deletion (Figs.
2A–C).
Histology
The histological results demonstrated loss of outer
hair cells that is typically observed with aging. The differ-
ences between the groups showed less hair cell loss in the
restricted-diet group and a slight reduction in hair cell
loss in the treated animals as compared with the control
subjects. Fig. 3A and B shows cochlear histograms from
the diet-restricted and placebo groups, respectively.
DISCUSSION
The results of this prospective study demonstrate
that with the normal aging process (the placebo group)
there is a progressive reduction in auditory sensitivity
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tion in hearing accelerates during the last 12 months of
life. Furthermore, there is an age-appropriate accumula-
tion of the common mtDNA deletion. This progression of
age-related hearing loss and accumulation of mtDNA de-
letions can be attenuated by long-term treatment with
antioxidants and scavengers of ROM. The findings ob-
served in the histological results are a bit more difficult to
interpret, but overall, they support these conclusions.
Presbyacusis or age-related hearing loss is the lead-
ing cause of hearing loss in the world, creating a signifi-
cant burden not only for the sufferers, but also for those
who communicate with them. The medical and socioeco-
nomic costs are staggering, and with the expansion of the
world population and the numbers of elderly individuals
expecting to more than double by the year 2030, this
problem is escalating.
There is significant evidence supporting the concept
that altered blood flow and/or oxygen delivery results in
hair cell damage. Atrophy of striae has been reported in
elderly human cadavers, even in the absence of classic
atherosclerotic changes.
18 Similar changes have been
identified in the stria vascularis of gerbils.
59 Prazma et
al.
19 have observed diminished flow in capillaries of the
basal turn of the cochlea, and blood viscosity and red blood
cell rigidity appear to correlate with high-frequency hear-
ing loss in elderly human subjects.
20 A relationship be-
tween vascular atrophy and presbyacusis has been pro-
posed.
60 In addition, studies have demonstrated a
significant reduction in erythrocyte velocity, increased
vascular permeability, a trend for reduced capillary diam-
eters, and a decrease in auditory sensitivity with aging.
2
Thus genetics, dietary factors, and environment have been
suspected to play a pivotal, yet poorly defined, role. The
current experiments support previous literature and ex-
pand on earlier findings by observing the progression of
Fig. 1. Auditory thresholds of the tested groups at the last auditory brainstem response (ABR) recording across all five frequencies. The X-axis
plots frequency; the Y-axis plots decibels.
TABLE I.
Overall Treatment Effect for Adjusted Averages Over Various
Observation Intervals.
Frequency
(Hz)
Month
25 Only
(n 5 25)
Month
20–25
(n 5 59–66)
Month
15–25
(n 5 108–116)
Month
12–25
(n 5 180–198)
3,000 .005 .009 ,.001 ,.001
6,000 .007 ,.001 ,.001 ,.001
9,000 .001 ,.001 ,.001 ,.001
12,000 .007 ,.001 ,.001 ,.001
18,000 .208 .114 .005 ,.001
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Furthermore, the identification of significant protection of
auditory thresholds in the diet-restricted groups and the
partial protection observed in the treated subjects in com-
parison with the placebo group support the hypothesis of
this proposal; specifically, diet restriction, which reduces
the formation of ROM, and antioxidants, which attenuate
age-associated hearing loss.
Fig. 2. A. Electrophoretic gel depicting the mitochondrial DNA data from stria vascularis. Similar data (not shown) exist for brain and auditory
nerve. The gel provides the data for identification of cytochrome b from stria vascularis. This represents a 365-base-pair (bp) product and
verifies the integrity of the polymerase chain reaction (PCR) and the presence of mitochondrial DNA. B. Data for identification of ND1–16S rRNA
from stria vascularis. This represents a 601-bp product and also verifies the integrity of the PCR and the presence of mitochondrial DNA. C.
Data identifying the 4,834-bp deletion (common aging deletion) from stria vascularis. This represents a 597-bp product. Lane 1 5 negative
control; lane 2 5 placebo; lane 3 5 diet restriction; lane 4 5 vitamin C; lane 5 5 vitamin E; lane 6 5 melatonin; lane 7 5 lazaroid; lane 8 5
molecular weight standard curve. DNA concentrations were normalized to 200 ng/50 mL of PCR reactant.
Fig. 3. A. Representative animal cochlea from a diet-restricted subject (original magnification 3 400) . Note the three outer hair cell rows (1,
2, and 3). There are some hair cells missing, which correlates well with the moderate degree of hearing loss noted on ABR testing. B.
Representative animal cochlea from a placebo subject (original magnification 3 400). Note the three outer hair cell rows (1, 2, 3). There are
many hair cells missing, which correlates well with the severe-profound hearing loss noted on ABR testing.
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735This report represents the first prospective random-
ized study designed to investigate the effect of antioxi-
dants, nutritional supplementation, and dietary restric-
tion on hearing loss specifically and on aging in general.
Furthermore, these studies propose that the mechanism
involving the generation of ROM and resultant damage to
mitochondria may be responsible in part for presbyacusis.
The observations from this study that dietary restric-
tion and other nutrient supplementation reduce the pro-
gression of age-related hearing loss is an important initial
step toward outlining strategies that may slow the pro-
gression of presbyacusis. All of the interventions used
affect the generation of ROM.
There is an increasing body of evidence implicating
ROM in the damage associated with cochlear ischemia,
noise trauma, aging, presbyacusis, and ototoxicity. Specif-
ically, localized inner ear ischemia and hypoxia induced
via selectively clamping the anterior inferior cerebellar
artery normally abolishes the compound action potential
within seconds and the effect becomes permanent after 8
minutes of ischemia. When subjects were pretreated with
allopurinol or superoxide dismutase followed by ischemia,
compound action potential thresholds were maintained.
61
In addition, these experiments were extended to study
noise- induced hearing loss, which, like aging, has also
been shown to cause vascular perturbations.
Despite the potential for prevention of some of these
disorders using antioxidants, there are other studies
which have not demonstrated a benefit of treatment using
antioxidant compounds such as superoxide dismutase
(SOD)
62,63 and a-tocopherol.
64 Critical analysis of these
negative studies reveals several flaws ranging from insuf-
ficient statistical power to lack of appropriate controls, use
of the wrong conjugates of SOD (i.e., those with a short
half-life of 1–4 s), and design difficulties. For example, one
study gave SOD 8 hours after closed-head injury, when
the majority of the damage had already occurred.
62
There is a significant body of literature providing
evidence that oxidative damage is important in the aging
process. It has been demonstrated that life span differ-
ences in certain rodent and primate species depend in part
on free radical scavenging systems. Investigators ob-
served that animals with longer life spans had higher
levels of SOD activity.
65 Many studies have investigated
dietary increases in antioxidants and have demonstrated
life span increases of 13% to 30%.
66,67
Metabolic rate is also closely linked to the aging
process. Many investigators have shown an inverse rela-
tionship between metabolic rate and life span.
68,69 The
relationship between aging and metabolic rate is clear
because the production of toxic oxygen radicals is propor-
tional to the rate of oxygen utilization (i.e., the metabolic
rate), and this has a close direct relationship with dietary
intake. Collectively, these studies provide both indirect
and direct evidence that ROM are responsible for many
clinical diseases including cochlear damage from isch-
emia, noise, and, possibly, aging.
The results of the mitochondrial experiments clearly
demonstrate the highest amount of the common aging
deletion in the placebo subjects with the least numbers of
deletions observed in the diet-restricted group. There was
a trend showing fewer deletions in the treated groups
compared with placebo. Given the long-term effect of dam-
age to cells and tissues exposed to the normal amounts of
ROM, the findings of protection in auditory sensitivity and
mtDNA deletions are encouraging.
The results of this study clearly demonstrate a pro-
tective effect of dietary restriction and nutritional over-
supplementation on age-related hearing loss and mtDNA
deletions. This beneficial effect most likely represents a
slowing of the mitochondrial clock theory of aging. Specif-
ically, dietary restriction and other mechanisms aimed at
reducing the overall burden of ROM provide an internal
milieu that is more favorable to the organism. The find-
ings support that the other treatment arms were protec-
tive overall. Vitamins E and C, melatonin, and lazaroid
appear to offer at least a partial protective effect. This
effect is not as evident as with dietary restriction. This
limited benefit may be explained in part by the fact that
each animal was oversupplemented with individual com-
pounds. There is compelling evidence that supplementing
with only one antioxidant may not be as effective as sup-
plementing with multiple antioxidants. This makes tele-
ological sense when considering that nutritional antioxi-
dants work by a variety of mechanisms. Some stabilize cell
membranes, others scavenge ROM molecules, yet others
enhance the role of other antioxidants. However, in exper-
imental design, it is crucial to test supplements individu-
ally, first, to elucidate specific properties and effects.
Based on such experimentation, studies subsequently can
be designed to observe the effect of supplements in com-
bination. Indeed, experiments to investigate such a com-
bined effect have clearly shown a synergistic positive ef-
fect on generalized system function.
70 Furthermore,
ongoing studies in our laboratory are addressing this spe-
cific issue using a combination of vitamins and compounds
that can enhance mitochondrial function.
CONCLUSION
This study presents empirical evidence in support of
an integrated hypothesis of aging and presbyacusis. In
addition, presented data provide a framework for the con-
tinuing identification and evolution of pharmacological
and nutritional strategies designed to attenuate age-
associated hearing loss. Areas of scientific inquiry have
also been identified that require further investigation
with the ultimate goal of enhancing our understanding of
the mechanisms that surround senescence, both as a phe-
nomenon and as an intrinsic biological property.
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